Asical Soft Capsule (Alfacalcidol)

Adult dose

Chronic renal failure and osteoporosis: Administer 0.5-1 ㎍ orally once daily as Alfacalcidol. Hypoparathyroidism and other diseases associated with vitamin D metabolic abnormalities: Administer 1-4 ㎍ orally once daily as this medication.

Child dose

Osteoporosis: Administer 0.01-0.03 ㎍ per kg of body weight orally once daily as Alfacalcidol. Other conditions: Administer 0.05-0.1 ㎍ per kg of body weight orally once daily as this medication.

This medication should not be administered to patients with hypercalcemia, hyperphosphatemia, or hypermagnesemia. It should also be avoided in individuals with a product of calcium and phosphorus in the blood exceeding a certain level, or those with excessive alkalinity in the blood, or those with symptoms of vitamin D overdose. Individuals who are hypersensitive to any of the ingredients in this medication or to vitamin D should avoid taking it. During treatment, it is advisable not to take medications that contain magnesium, vitamin D or its derivatives, calcium-containing medications, or certain diuretics concurrently. If the medication is taken during breastfeeding, it is advisable to avoid taking it if possible, and if it must be taken, to stop breastfeeding. Women who are pregnant or may become pregnant should consult a doctor before taking it, as it may affect the fetus. The safety of this medication in children and the elderly has not been fully established, so dosage adjustment and monitoring of blood calcium levels are necessary. Patients taking certain drugs should consult a doctor or pharmacist regarding possible interactions with this medication. If any adverse effects occur during treatment, discontinue use immediately and consult a healthcare professional, as symptoms can appear in various systems including digestive, nervous, cardiac, renal, liver, skin, eyes, and bone. Regularly check serum calcium levels and kidney function, and seek appropriate measures if abnormalities are detected. In case of overdose, emergency treatment such as inducing vomiting or gastric lavage may be necessary, and medication should be stopped until serum calcium levels return to normal. This medication should be stored out of reach of children, protected from direct sunlight, and kept in a cool, dry place. To maintain quality, it is important not to transfer it to other containers.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough + fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusional state, visual disturbances, paralysis, urination changes

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• discomfort in the upper stomach
• abdominal bloating
• indigestion
• thirst

This medication may be sensitive to light, so it should be stored in a tightly sealed container that blocks light. Moreover, it is important to keep it at room temperature, which means not too hot or cold, to maintain the efficacy of the medication.

Appearance

Yellow soft capsule containing a colorless transparent oily substance

Package unit

60 capsules/PTP [(10 capsules/PTP * 6)], 120 capsules/box [(10 capsules/PTP * 6) x 2], 30 capsules/bottle